Biomarkers in the Diagnosis of Aspergillosis

Laura Rivera-Agudelo1, Diego H Cáceres2,3,4, Julián C Arango-Rincón1,5

  • 1Grupo de Micología Médica y Experimental, Corporación para Investigaciones Biológicas CIB-UdeA-UPB-UDES, Medellín 050010, Colombia.

Insights

Accurate diagnosis of aspergillosis requires multiple tests. Biomarkers, including membrane components, DNA, and metabolic products, aid in early detection and treatment of Aspergillus infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases

Background:

  • Aspergillosis encompasses diverse invasive and non-invasive diseases caused by *Aspergillus* species.
  • Treatment complications and rising antifungal resistance in *Aspergillus* present significant challenges.

Purpose of the Study:

  • To review biomarkers for diagnosing aspergillosis.
  • To assess the utility and performance of various diagnostic biomarkers.

Main Methods:

  • Review of existing studies on aspergillosis biomarkers.
  • Categorization of biomarkers into membrane components, DNA sequences, and metabolic products.

Main Results:

  • Biomarker detection is a key advancement in medical mycology.
  • Diagnostic aids enable prompt identification of *Aspergillus* infections.
  • Early detection facilitates timely antifungal therapy.

Conclusions:

  • Combined diagnostic approaches are essential for accurate aspergillosis diagnosis.
  • Biomarkers significantly improve the speed and accuracy of diagnosing *Aspergillus* diseases.
  • Biomarker utilization reduces the time to initiate antifungal treatment.